VBI Vaccines Inc.
VBIV · NASDAQ
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Market Cap | $15 | $14 | $14 | $28 |
| - Cash | $13 | $24 | $35 | $21 |
| + Debt | $51 | $53 | $50 | $53 |
| Enterprise Value | $53 | $43 | $29 | $60 |
| Revenue | $1 | $1 | $7 | $1 |
| % Growth | 42.3% | -87.1% | 820% | – |
| Gross Profit | -$2 | -$3 | $4 | -$3 |
| % Margin | -124.4% | -300.6% | 61.9% | -383.8% |
| EBITDA | -$15 | $3 | -$18 | -$37 |
| % Margin | -1,268% | 296.4% | -270% | -5,135% |
| Net Income | -$18 | -$0 | -$20 | -$45 |
| % Margin | -1,474.5% | -1.5% | -308.6% | -6,198.3% |
| EPS Diluted | -0.73 | -0.001 | -0.97 | -5.18 |
| % Growth | -145,900% | 99.9% | 81.3% | – |
| Operating Cash Flow | -$12 | -$11 | -$8 | -$19 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$12 | -$11 | -$8 | -$19 |